借鉴美国和欧盟经验完善我国药品再注册制度
郑洋洋1,董 志1*,夏永鹏2
借鉴美国和欧盟经验完善我国药品再注册制度
Learning American and European Union Experience to Perfect Re-registration of Drugs in China
{{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
/
〈 |
|
〉 |